Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of ARS 159.33 trillion. The enterprise value is 212.24 trillion.

Market Cap	159.33T
Enterprise Value	212.24T

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 18.87 and the forward PE ratio is 8.43.

PE Ratio	18.87
Forward PE	8.43
PS Ratio	2.38
PB Ratio	1.64
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.37, with an EV/FCF ratio of 17.66.

EV / Earnings	25.14
EV / Sales	2.91
EV / EBITDA	7.37
EV / EBIT	10.94
EV / FCF	17.66

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.69.

Current Ratio	1.26
Quick Ratio	0.88
Debt / Equity	0.69
Debt / EBITDA	2.55
Debt / FCF	5.56
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.52%.

Return on Equity (ROE)	8.62%
Return on Assets (ROA)	4.79%
Return on Invested Capital (ROIC)	6.52%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	825.91M
Profits Per Employee	104.23M
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.47

Taxes

Income Tax	-546.21B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.16% in the last 52 weeks. The beta is 0.49, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-21.16%
50-Day Moving Average	6,942.40
200-Day Moving Average	7,816.60
Relative Strength Index (RSI)	49.62
Average Volume (20 Days)	11,056

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.17

Income Statement

In the last 12 months, Pfizer had revenue of ARS 66.90 trillion and earned 8.44 trillion in profits. Earnings per share was 1,481.43.

Revenue	66.90T
Gross Profit	49.79T
Operating Income	17.61T
Pretax Income	7.91T
Net Income	8.44T
EBITDA	24.98T
EBIT	17.61T
Earnings Per Share (EPS)	1,481.43

Full Income Statement

Balance Sheet

The company has 18.55 trillion in cash and 66.83 trillion in debt, giving a net cash position of -48,278.54 billion.

Cash & Cash Equivalents	18.55T
Total Debt	66.83T
Net Cash	-48,278.54B
Net Cash Per Share	n/a
Equity (Book Value)	97.07T
Book Value Per Share	17,018.82
Working Capital	10.08T

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.98 trillion and capital expenditures -2,965.60 billion, giving a free cash flow of 12.02 trillion.

Operating Cash Flow	14.98T
Capital Expenditures	-2,965.60B
Free Cash Flow	12.02T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.42%, with operating and profit margins of 26.33% and 12.62%.

Gross Margin	74.42%
Operating Margin	26.33%
Pretax Margin	11.82%
Profit Margin	12.62%
EBITDA Margin	37.34%
EBIT Margin	26.33%
FCF Margin	17.96%

Dividends & Yields

This stock pays an annual dividend of 282.72, which amounts to a dividend yield of 3.97%.

Dividend Per Share	282.72
Dividend Yield	3.97%
Dividend Growth (YoY)	79.41%
Years of Dividend Growth	3
Payout Ratio	121.49%
Buyback Yield	-0.97%
Shareholder Yield	3.01%
Earnings Yield	5.30%
FCF Yield	7.54%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 2.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	2

Scores

Pfizer has an Altman Z-Score of 2.22 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	8